Yancy Telisa L
Director · DLX
As of 2026-09-16, Yancy Telisa L has 14 Form 4 transactions on record across 1 company — 7 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
- Direct $1.4M
- Indirect $0
| DLX | direct | 58,652 sh | $1.4M |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|
14 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-09-15 | DLX | Award / grant | 1,115 | 58,652 | Form 4 |
| 2026-06-15 | DLX | Award / grant | 1,168 | 57,537 | Form 4 |
| 2026-04-23 | DLX | Option exercise | 10,349 | 0 | Form 4 |
| 2026-04-23 | DLX | Award / grant | 5,286 | 5,286 | Form 4 |
| 2026-04-23 | DLX | Option exercise | 10,349 | 56,369 | Form 4 |
| 2026-03-13 | DLX | Other acquisition | 0 | 44,984 | Form 4 |
| 2025-12-15 | DLX | Other acquisition | 1,227 | 44,984 | Form 4 |
| 2025-09-15 | DLX | Award / grant | 1,399 | 43,757 | Form 4 |
| 2025-06-13 | DLX | Other acquisition | 1,864 | 42,358 | Form 4 |
| 2025-04-24 | DLX | Option exercise | 7,980 | 0 | Form 4 |
| 2025-04-24 | DLX | Award / grant | 10,349 | 10,349 | Form 4 |
| 2025-04-24 | DLX | Option exercise | 7,980 | 40,494 | Form 4 |
| 2025-03-14 | DLX | Other acquisition | 1,736 | 32,514 | Form 4 |
| 2024-12-13 | DLX | Other acquisition | 1,179 | 30,778 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.